Global COVID-19 Recombinant Protein Vaccine Market Growth (Status and Outlook) 2023-2029

March 2023 | 81 pages | ID: G93B9F2C3C8EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Preparation and immunogenicity and immunoprotection of Hib polysaccharide conjugate vaccine based on pneumococcal surface adhesive (PsaA).Methods PsaA gene recombinant protein (rPsaA) was prepared by genetic engineering, and then conjugated with Hib polysaccharide by amide condensation.The 3-week-old mice were immunized with this vaccine, and mice were inoculated with tetanus toxoid and haemophilus influenzae type B (Hib) polysaccharide conjugate vaccine (hib-tt) as controls and phosphate buffer (PBS) as blank controls.

According to this study, the global COVID-19 Recombinant Protein Vaccine market size will reach US$ million by 2029.

This report presents a comprehensive overview, market shares, and growth opportunities of COVID-19 Recombinant Protein Vaccine market by product type, application, key players and key regions and countries.

Segmentation by product type:

• Being Developed
• Preclinical
• Clinical I
• Clinical II

Segmentation by Application:

• Pharmaceutical And Biotechnology Companies
• Hospital
• Academic And Research Organizations
• Other

This report also splits the market by region:

• United States
• China
• Europe
• Other regions:
• Japan
• South Korea
• Southeast Asia
• Rest of world

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report:

• GSK
• Johnson & Johnson
• Sanofi
• Novavax
• Pukang Biologic Technology
• Clover Biopharmaceuticals
• Suzhou Yuzhibo Biotechnology

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global COVID-19 Recombinant Protein Vaccine Market Size 2024-2029
  2.1.2 COVID-19 Recombinant Protein Vaccine Market Size CAGR by Region
2.2 COVID-19 Recombinant Protein Vaccine Segment by Type
  2.2.1 Being Developed
  2.2.2 Preclinical
  2.2.3 Clinical I
  2.2.4 Clinical II
2.3 COVID-19 Recombinant Protein Vaccine Market Size by Type
  2.3.1 Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2024-2029)
  2.3.2 Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate by Type (2024-2029)
2.4 COVID-19 Recombinant Protein Vaccine Segment by Application
  2.4.1 Pharmaceutical And Biotechnology Companies
  2.4.2 Hospital
  2.4.3 Academic And Research Organizations
  2.4.4 Other
2.5 COVID-19 Recombinant Protein Vaccine Market Size by Application
  2.5.1 Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2024-2029)
  2.5.2 Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate by Application (2024-2029)

3 COVID-19 RECOMBINANT PROTEIN VACCINE KEY PLAYERS

3.1 Date of Key Players Enter into COVID-19 Recombinant Protein Vaccine
3.2 Key Players COVID-19 Recombinant Protein Vaccine Product Offered
3.3 Key Players COVID-19 Recombinant Protein Vaccine Funding/Investment Analysis
3.4 Funding/Investment
  3.4.1 Funding/Investment by Regions
  3.4.2 Funding/Investment by End-Industry
3.5 Key Players COVID-19 Recombinant Protein Vaccine Valuation & Market Capitalization
3.6 Key Players Mergers & Acquisitions, Expansion Plans
3.7 Market Ranking
3.8 New Product/Technology Launches
3.9 Partnerships, Agreements, and Collaborations
3.10 Mergers and Acquisitions

4 COVID-19 RECOMBINANT PROTEIN VACCINE BY REGIONS

4.1 COVID-19 Recombinant Protein Vaccine Market Size by Regions (2024-2029)
4.2 United States COVID-19 Recombinant Protein Vaccine Market Size Growth (2024-2029)
4.3 China COVID-19 Recombinant Protein Vaccine Market Size Growth (2024-2029)
4.4 Europe COVID-19 Recombinant Protein Vaccine Market Size Growth (2024-2029)
4.5 Rest of World COVID-19 Recombinant Protein Vaccine Market Size Growth (2024-2029)

5 UNITED STATES

5.1 United States COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029)
5.2 United States COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029)

6 EUROPE

6.1 Europe COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029)
6.2 Europe COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029)

7 CHINA

7.1 China COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029)
7.2 China COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029)

8 REST OF WORLD

8.1 Rest of World COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029)
8.2 Rest of World COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029)
8.3 Japan
8.4 South Korea
8.5 Southeast Asia

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 KEY INVESTORS IN COVID-19 RECOMBINANT PROTEIN VACCINE

10.1 Company A
  10.1.1 Company A Company Details
  10.1.2 Company Description
  10.1.3 Companies Invested by Company A
  10.1.4 Company A Key Development and Market Layout
10.2 Company B
  10.2.1 Company B Company Details
  10.2.2 Company Description
  10.2.3 Companies Invested by Company B
  10.2.4 Company B Key Development and Market Layout
10.3 Company C
  10.3.1 Company C Company Details
  10.3.2 Company Description
  10.3.3 Companies Invested by Company C
  10.3.4 Company C Key Development and Market Layout
10.4 Company D
10.5 ……

11 KEY PLAYERS ANALYSIS

11.1 GSK
  11.1.1 GSK Company Details
  11.1.2 GSK COVID-19 Recombinant Protein Vaccine Product Offered
  11.1.3 GSK COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
  11.1.4 GSK Main Business Overview
  11.1.5 GSK News
11.2 Johnson & Johnson
  11.2.1 Johnson & Johnson Company Details
  11.2.2 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Product Offered
  11.2.3 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
  11.2.4 Johnson & Johnson Main Business Overview
  11.2.5 Johnson & Johnson News
11.3 Sanofi
  11.3.1 Sanofi Company Details
  11.3.2 Sanofi COVID-19 Recombinant Protein Vaccine Product Offered
  11.3.3 Sanofi COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
  11.3.4 Sanofi Main Business Overview
  11.3.5 Sanofi News
11.4 Novavax
  11.4.1 Novavax Company Details
  11.4.2 Novavax COVID-19 Recombinant Protein Vaccine Product Offered
  11.4.3 Novavax COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
  11.4.4 Novavax Main Business Overview
  11.4.5 Novavax News
11.5 Pukang Biologic Technology
  11.5.1 Pukang Biologic Technology Company Details
  11.5.2 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Product Offered
  11.5.3 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
  11.5.4 Pukang Biologic Technology Main Business Overview
  11.5.5 Pukang Biologic Technology News
11.6 Clover Biopharmaceuticals
  11.6.1 Clover Biopharmaceuticals Company Details
  11.6.2 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Product Offered
  11.6.3 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
  11.6.4 Clover Biopharmaceuticals Main Business Overview
  11.6.5 Clover Biopharmaceuticals News
11.7 Suzhou Yuzhibo Biotechnology
  11.7.1 Suzhou Yuzhibo Biotechnology Company Details
  11.7.2 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Product Offered
  11.7.3 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
  11.7.4 Suzhou Yuzhibo Biotechnology Main Business Overview
  11.7.5 Suzhou Yuzhibo Biotechnology News
...

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. COVID-19 Recombinant Protein Vaccine Market Size CAGR by Region (2024-2029) ($ Millions)
Table 2. Major Players of Being Developed
Table 3. Major Players of Preclinical
Table 4. Major Players of Clinical I
Table 5. Major Players of Clinical II
Table 6. Global COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 7. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2024-2029)
Table 8. Global COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 9. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2024-2029)
Table 10. Date of Global Key Players Enter into COVID-19 Recombinant Protein Vaccine Market
Table 11. Global Key Players COVID-19 Recombinant Protein Vaccine Product Offered
Table 12. Key Players COVID-19 Recombinant Protein Vaccine Funding/Investment ($ Millions)
Table 13. Funding/Investment by Regions
Table 14. Funding/Investment by End Industry
Table 15. Key Players COVID-19 Recombinant Protein Vaccine Valuation & Market Capitalization ($ Millions)
Table 16. Key Players Mergers & Acquisitions, Expansion Plans
Table 17. COVID-19 Recombinant Protein Vaccine New Product/Technology Launches
Table 18. COVID-19 Recombinant Protein Vaccine Industry Partnerships, Agreements, and Collaborations
Table 19. COVID-19 Recombinant Protein Vaccine Industry Mergers and Acquisitions
Table 20. Global COVID-19 Recombinant Protein Vaccine Market Size by Regions 2024-2029 ($ Millions)
Table 21. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Regions 2024-2029
Table 22. United States COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 23. United States COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2024-2029)
Table 24. United States COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 25. United States COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2024-2029)
Table 26. Europe COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 27. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2024-2029)
Table 28. Europe COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 29. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2024-2029)
Table 30. China COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 31. China COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2024-2029)
Table 32. China COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 33. China COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2024-2029)
Table 34. Rest of World COVID-19 Recombinant Protein Vaccine Market Size by Type (2024-2029) ($ Millions)
Table 35. Rest of World COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2024-2029)
Table 36. Rest of World COVID-19 Recombinant Protein Vaccine Market Size by Application (2024-2029) ($ Millions)
Table 37. Rest of World COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2024-2029)
Table 38. Key Market Drivers & Growth Opportunities of COVID-19 Recombinant Protein Vaccine
Table 39. Key Market Challenges & Risks of COVID-19 Recombinant Protein Vaccine
Table 40. Key Industry Trends of COVID-19 Recombinant Protein Vaccine
Table 41. Company A Company Details
Table 42. Companies Invested by Company A
Table 43. Company A Key Development and Market Layout
Table 44. Company B Company Details
Table 45. Companies Invested by Company B
Table 46. Company B Key Development and Market Layout
Table 47. Company C Company Details
Table 48. Companies Invested by Company C
Table 49. Company C Key Development and Market Layout
Table 50. Company C Company Details
Table 51. Companies Invested by Company C
Table 52. Company C Key Development and Market Layout
Table 53. GSK Basic Information, Head Office, Major Market Areas and Its Competitors
Table 54. GSK COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
Table 55. Johnson & Johnson Basic Information, Head Office, Major Market Areas and Its Competitors
Table 56. Johnson & Johnson COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
Table 57. Sanofi Basic Information, Head Office, Major Market Areas and Its Competitors
Table 58. Sanofi COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
Table 59. Novavax Basic Information, Head Office, Major Market Areas and Its Competitors
Table 60. Novavax COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
Table 61. Pukang Biologic Technology Basic Information, Head Office, Major Market Areas and Its Competitors
Table 62. Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
Table 63. Clover Biopharmaceuticals Basic Information, Head Office, Major Market Areas and Its Competitors
Table 64. Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)
Table 65. Suzhou Yuzhibo Biotechnology Basic Information, Head Office, Major Market Areas and Its Competitors
Table 66. Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Market Size (2023 VS 2029)

List Of Figures

LIST OF FIGURES

Figure 1. Picture of COVID-19 Recombinant Protein Vaccine
Figure 2. COVID-19 Recombinant Protein Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global COVID-19 Recombinant Protein Vaccine Market Size Growth Rate 2024-2029 ($ Millions)
Figure 7. COVID-19 Recombinant Protein Vaccine Market Size by Region (2023 & 2029) ($ millions)
Figure 8. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Type (2024-2029)
Figure 9. Global Being Developed Market Size Growth Rate
Figure 10. Global Preclinical Market Size Growth Rate
Figure 11. Global Clinical I Market Size Growth Rate
Figure 12. Global Clinical II Market Size Growth Rate
Figure 13. COVID-19 Recombinant Protein Vaccine in Pharmaceutical And Biotechnology Companies
Figure 14. Global COVID-19 Recombinant Protein Vaccine Market: Pharmaceutical And Biotechnology Companies (2024-2029) ($ Millions)
Figure 15. COVID-19 Recombinant Protein Vaccine in Hospital
Figure 16. Global COVID-19 Recombinant Protein Vaccine Market: Hospital (2024-2029) ($ Millions)
Figure 17. COVID-19 Recombinant Protein Vaccine in Academic And Research Organizations
Figure 18. Global COVID-19 Recombinant Protein Vaccine Market: Academic And Research Organizations (2024-2029) ($ Millions)
Figure 19. COVID-19 Recombinant Protein Vaccine in Other
Figure 20. Global COVID-19 Recombinant Protein Vaccine Market: Other (2024-2029) ($ Millions)
Figure 21. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application (2024-2029)
Figure 22. Global COVID-19 Recombinant Protein Vaccine Market Size in Pharmaceutical And Biotechnology Companies Growth Rate
Figure 23. Global COVID-19 Recombinant Protein Vaccine Market Size in Hospital Growth Rate
Figure 24. Global COVID-19 Recombinant Protein Vaccine Market Size in Academic And Research Organizations Growth Rate
Figure 25. Global COVID-19 Recombinant Protein Vaccine Market Size in Other Growth Rate
Figure 26. Funding/Investment
Figure 27. Global COVID-19 Recombinant Protein Vaccine Market Size Market Share by Regions 2024-2029
Figure 28. United States COVID-19 Recombinant Protein Vaccine Market Size 2024-2029 ($ Millions)
Figure 29. China COVID-19 Recombinant Protein Vaccine Market Size 2024-2029 ($ Millions)
Figure 30. Europe COVID-19 Recombinant Protein Vaccine Market Size 2024-2029 ($ Millions)
Figure 31. Rest of World COVID-19 Recombinant Protein Vaccine Market Size 2024-2029 ($ Millions)
Figure 32. United States COVID-19 Recombinant Protein Vaccine Consumption Market Share by Type in 2029
Figure 33. United States COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2029
Figure 34. China COVID-19 Recombinant Protein Vaccine Consumption Market Share by Type in 2029
Figure 35. China COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2029
Figure 36. Europe COVID-19 Recombinant Protein Vaccine Consumption Market Share by Type in 2029
Figure 37. Europe COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2029
Figure 38. Rest of World COVID-19 Recombinant Protein Vaccine Consumption Market Share by Type in 2029
Figure 39. Rest of World COVID-19 Recombinant Protein Vaccine Market Size Market Share by Application in 2029